Continuing to strengthen FDA's science approach to emerging technologies
详细信息 查看全文
- 作者：Rachael Anatol ; PhD ; Steven Bauer ; PhD ; Suzanne Epstein ; PhD ; Ross Filice ; MD ; Kristina Lauritsen ; PhD ; Mark H. Lee ; PhD ; Elizabeth Mansfield ; PhD ; Michelle McMurry-Heath ; PhD ; Joseph Milone ; PhD ; Carlos Peñ ; a ; PhD ; carlos.pena@fda.hhs.gov ; Steven Pollack ; PhD ; Issam Zineh ; PharmD ; MPH ; FCCP
- 关键词：FDA ; Science ; Emerging technologies
- 刊名：Nanomedicine: Nanotechnology, Biology and Medicine
- 出版年：2013
- 出版时间：July, 2013
- 年：2013
- 卷：9
- 期：5
- 页码：594-599
- 全文大小：322 K
文摘
Emerging technologies result when advances and innovation in technology lead to discoveries. Often emerging technologies stimulate novel research in medical product development that contribute to new approaches to manufacturing and can improve the quality of products. By supporting investments in agency coordination, staff training and professional development, regulatory science research, stakeholder engagement, and enhancing opportunities for expert input, the U.S. Food and Drug Administration plays a critical role in translating innovations into novel safe and effective medical products that improve the public health.